The immune system fights viruses with peptides. Now, scientists have treated animal models of herpes with synthetic peptide mimics known as peptoids. These molecules could one day cure or prevent many kinds of infections, including COVID-19. They will present their results at ACS Fall 2021.
Researchers at Stanford and Berkeley Lab’s Molecular Foundry have developed virus-killing molecules called peptoids. The technology could make possible an emerging category of antiviral drugs that could treat everything from herpes and COVID-19 to the common cold.
Scientists at Berkeley Lab and Stanford have joined forces to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.